Why Madrigal Pharmaceuticals Stock Is Crushing It Today

Shares of Madrigal Pharmaceuticals (MDGL 222.12%) had skyrocketed by 243.7% as of 11:11 a.m. ET on Monday. The huge gain came after the company announced positive results from a phase 3 clinical study evaluating its experimental drug resmetirom as a treatment for nonalcoholic steatohepatitis…#madrigalpharmaceuticals #nafld #nash #nas #fda #nonalcoholic #foodanddrugadministration
Source: Reuters: Health - Category: Consumer Health News Source Type: news